Related references
Note: Only part of the references are listed.CGRP antagonists and antibodies for the treatment of migraine
Laszlo Vecsei et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Correlation between Migraine Severity and Cholesterol Levels
Claudio Tana et al.
PAIN PRACTICE (2015)
Targeting TRP Channels For Novel Migraine Therapeutics
Gregory Dussor et al.
ACS CHEMICAL NEUROSCIENCE (2014)
The TRPA1 channel in migraine mechanism and treatment
S. Benemei et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
BMS-927711 for the acute treatment of migraine
Marcelo E. Bigal
CEPHALALGIA (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs
Peer C. Tfelt-Hansen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
COX inhibitors for the treatment of migraine
Stephen D. Silberstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Treatment of menstrual migraine: utility of control of related mood disturbances
Andrea Negro et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
Sarah Walter et al.
MABS (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
Paul B. Rizzoli
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
Deepak K. Bhatt et al.
CEPHALALGIA (2013)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
CGRP Receptor Antagonism and Migraine Therapy
Lars Edvinsson et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies
Sieneke Labruijere et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies
Todd A. Smitherman et al.
HEADACHE (2013)
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders
Paolo Martelletti et al.
JOURNAL OF HEADACHE AND PAIN (2013)
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?
Claudio Tana et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Measuring the Global Burden of Disease
Christopher J. L. Murray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel
Serena Materazzi et al.
PAIN (2013)
Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
Rodrigo Noseda et al.
PAIN (2013)
Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura
Philip R. Holland et al.
ANNALS OF NEUROLOGY (2012)
Emerging treatment for chronic migraine and refractory chronic migraine
Luana Lionetto et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Markus Farkkila et al.
LANCET NEUROLOGY (2012)
Odors as triggering and worsening factors for migraine in men
Andressa Marmore de Lima et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2011)
Myofascial pain syndromes and their evaluation
Maria Adele Giamberardino et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
Chronic Migraine, Classification, Differential Diagnosis, and Epidemiology
Richard B. Lipton
HEADACHE (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Thalamic Sensitization Transforms Localized Pain into Widespread Allodynia
Rami Burstein et al.
ANNALS OF NEUROLOGY (2010)
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
Hans Olav Hoivik et al.
CEPHALALGIA (2010)
5-Hydroxyptryptamine IF (5-HTIF) receptor agonism. A possible new treatment principle for acute migraine attacks
Jes Olesen
CEPHALALGIA (2010)
Preclinical pharmacological profile of the selective 5-HTIF receptor agonist lasmiditan
David L. Nelson et al.
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults
Tae H. Han et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
Nitric Oxide-Related Drug Targets in Headache
Jes Olesen
NEUROTHERAPEUTICS (2010)
Acid-Sensing Ion Channels (ASICs): Pharmacology and implication in pain
Emmanuel Deval et al.
PHARMACOLOGY & THERAPEUTICS (2010)
The vascular theory of migrainea great story wrecked by the facts
Peter J. Goadsby
BRAIN (2009)
A Randomized, Controlled Study Comparing a Lidocaine Patch, a Placebo Patch, and Anesthetic Injection for Treatment of Trigger Points in Patients With Myofascial Pain Syndrome: Evaluation of Pain and Somatic Pain Thresholds
Giannapia Affaitati et al.
CLINICAL THERAPEUTICS (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
The concept of neurogenic inflammation
Pierangelo Geppetti et al.
BJU INTERNATIONAL (2008)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily
A. Nicoletti et al.
CEPHALALGIA (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Contribution of Myofascial trigger points to migraine symptoms
Maria Adele Glamberardino et al.
JOURNAL OF PAIN (2007)
The triggers or precipitants of the acute migraine attack
L. Kelman
CEPHALALGIA (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Response properties of dural nociceptors in relation to headache
AM Strassman et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Migraine: Epidemiology, impact, and risk factors for progression
RB Lipton et al.
HEADACHE (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine:: a randomised controlled trial
DJ Goldstein et al.
LANCET (2001)
Nitric oxide in primary headaches
LL Thomsen et al.
CURRENT OPINION IN NEUROLOGY (2001)
Mechanisms of migraine aura revealed by functional MRI in human visual cortex
N Hadjikhani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Tbe development of cutaneous allodynia during a migraine attack - Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine
R Burstein et al.
BRAIN (2000)
Share Paper
